Sciascia Thomas Insider Trades

Insider Trading History

Track insider trading activity for Sciascia Thomas. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $1.52M 85,000 shares
Last Trade
Feb 19, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$898k 85,000 shares
$10.56
$17.91
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $1.65M 92,000 shares
Last Trade
May 31, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$391k 60,000 shares
$6.51
$17.91
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $0 0 shares
Last Trade
Mar 25, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$17.4k 2,631 shares
$6.61
$17.91
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $3.96M 221,373 shares
Last Trade
Mar 25, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$17.4k 2,631 shares
$6.60
$17.91
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $4.01M 224,004 shares
Last Trade
Mar 25, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$17.4k 2,631 shares
$6.61
$17.91
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $573k 32,000 shares
Last Trade
Mar 10, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$194k 32,000 shares
$6.07
$17.91
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $2.08M 116,000 shares
Last Trade
Feb 18, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$490k 116,000 shares
$4.22
$17.91
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $4.24M 236,811 shares
Last Trade
Aug 19, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$49k 16,496 shares
$2.97
$17.91
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $0 0 shares
Last Trade
Aug 19, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$49k 16,496 shares
$2.97
$17.91
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $3.95M 220,315 shares
Last Trade
Aug 19, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$48.8k 16,496 shares
$2.96
$17.91
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $4.28M 238,975 shares
Last Trade
Aug 16, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$51.7k 18,660 shares
$2.77
$17.91
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $3.95M 220,315 shares
Last Trade
Aug 16, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$51.5k 18,660 shares
$2.76
$17.91
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $295k 16,496 shares
Last Trade
Aug 16, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$51.7k 18,660 shares
$2.77
$17.91
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $630k 35,156 shares
Last Trade
Aug 15, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$35k 12,745 shares
$2.75
$17.91
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $3.95M 220,315 shares
Last Trade
Aug 15, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$35.6k 12,745 shares
$2.79
$17.91
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $4.17M 233,060 shares
Last Trade
Aug 15, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$35k 12,745 shares
$2.75
$17.91
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $3.95M 220,315 shares
Last Trade
Aug 14, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$275 100 shares
$2.75
$17.91
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $3.95M 220,415 shares
Last Trade
Aug 14, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$261 100 shares
$2.61
$17.91
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $858k 47,901 shares
Last Trade
Aug 14, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$261 100 shares
$2.61
$17.91
Trevi Therapeutics
Trevi Therapeutics TRVI
Chief Scientific Officer
Holding Value $3.84M 214,433 shares
Last Trade
May 29, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$136k 53,368 shares
$2.55
$17.91

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up